For example, M7824 is a bifunctional antibody targeting both TGF-β and the programmed death receptor-1/programmed death ligand 1 immune checkpoint pathways, which can significantly promote the activation of CD8+ T cells and NK cells, reduce tumor burden, and improve the survival of mice bearing breast cancer and colon cancer [85]. Here, TGFB1 is linked to neoplasm.